𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel: Beer TM, Ryan CW, Venner PM, Petrylak DP, Chatta GS, Ruether JD, Chi KN, Young J, Henner WD, ASCENT (AIPC Study of Calcitriol Enhancing Taxotere) Investigators, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR

✍ Scribed by Donald L. Trump


Book ID
116956350
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
42 KB
Volume
26
Category
Article
ISSN
1078-1439

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Intermittent chemotherapy in patients wi
✍ Tomasz M. Beer; Christopher W. Ryan; Peter M. Venner; Daniel P. Petrylak; Gurkam 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## BACKGROUND. Survival in patients with metastatic, chemotherapy‐naive, androgen‐independent prostate cancer (AIPC) is improved with 10 to 12 cycles of docetaxel‐containing chemotherapy but further management is undefined. In the current study, the authors examined retreatment with th